ask="N/A"
ask_size="N/A"
average_daily_volume="59753"
bid="14.50"
bid_size="1000"
book_value="6.38"
change="+0.07"
change_from_200_day_moving_average="-0.53"
change_from_50_day_moving_average="-1.35"
change_from_52_week_high="-4.90"
change_From_52_week_low="2.78"
change_in_percent="+0.44%"
close="15.84"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-8.72"
ebitda="-48.18M"
eps_estimate_current_year="-4.11"
eps_estimate_next_quarter="-0.77"
eps_estimate_next_year="-3.46"
ex_dividend_date="N/A"
float_shares="6846000"
high="16.07"
high_52_weeks="20.74"
last_trade_date="1/30/2017"
last_trade_price="15.84"
last_trade_size="1255"
last_trade_time="4:00pm"
low="15.54"
low_52_weeks="13.06"
market_capitalization="344.12M"
moving_average_200_day="16.37"
moving_average_50_day="17.19"
name="Audentes Therapeutics
Inc."
notes="N/A"
one_year_target_price="22.33"
open="15.71"
pe_ratio="N/A"
peg_ratio="-1.45"
percent_change_from_200_day_moving_average="-3.25%"
percent_change_from_50_day_moving_average="-7.86%"
percent_change_from_52_week_high="-23.63%"
percent_change_from_52_week_low="+21.29%"
previous_close="15.77"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.47"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21725000"
short_ratio="4.62"
stock_exchange="NGM"
symbol="BOLD"
volume="19771"
weeks_range_52="13.06 - 20.74"
